Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 3, 2013, Pages 212-216

  Reich Slotky, Ronit ^a   Andrews, Jinsy ^b,c   Cheng, Bin ^a   Buchsbaum, Richard ^a   Levy, Diane ^a   Kaufmann, Petra ^d   Thompson, John L P ^a  

^a Mailman School of Public Health   (United States)

^b Hospital for Special Care New Britain   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d Howard Hughes Medical Institute   (United States)

Author keywords

ALS; ALSFRS R; BMI

Indexed keywords

UBIDECARENONE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; ARTICLE; BODY MASS; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DRUG MEGADOSE; FEMALE; FORCED VITAL CAPACITY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RATING SCALE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84875698098     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.770028     Document Type: Article

References (26)

1. Haverkamp LJ, Appel V, Appel SH. Natural history of amyo-trophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995; 118: 707-19.
2. Norris F, Shepherd R, Denys E, U K, Mukai E, Elias L, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993; 118: 48-55.
3. Valdmanis PN, Rouleau GA. Genetics of familial amyo-trophic lateral sclerosis. Neurology. 2008; 70: 144-52.
4. Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem. 2002; 80: 616-25.
5. Silani V, Kasarskis EJ, Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. J Neurol. 1998; 245 (Suppl 2): S13-9; discussion S29. Epub 1998/09/25.
6. Silva LB, Mourao LF, Silva AA, Lima NM, Almeida SR, Franca MC Jr, et al. Amyotrophic lateral sclerosis: combined nutritional, respiratory and functional assessment. Arq Neu-ropsiquiatr. 2008; 66: 354-9.
7. Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006; 7: 29.
8. Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med. 2007; 9: 17-20.
9. Okado-Matsumoto A, Fridovich I. Amyotrophic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci USA. 2002; 99: 9010-4.
10. Sinclair DA. Toward a unified theory of caloric restriction and longevity regulation. Mech Ageing Dev. 2005; 126: 987-1002.
11. Hardiman O. Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurol. 2000; 247: 245-51.
12. Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010; 11: 542-8.
13. Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle & Nerve. 2011; 44: 20-4.
14. Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, Gordon PH, et al. The ALSFRS-R predicts survival time in an ALS clinic population. Neurology. 2005; 64: 38-43.
15. Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, et al. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Annals of Neurology. 2009; 66: 235-44.
16. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences. 1999; 169: 13-21.
17. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle & Nerve. 2002; 25: 709-14.
18. Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and university athletics in ALS. Neurology. 2002; 59: 773-5. Epub 2002/09/11.
19. Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009; 72: 1087-94.
20. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68: 1002-7.
21. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009; 72: 1640-5.
22. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996; 63: 130-7.
23. Genton L, Viatte V, Janssens JP, Heritier AC, Pichard C. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clin Nutr. 2011; 30: 553-9.
24. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. An obesity paradox in acute heart failure: analysis of body mass index and in-hospital mortality for 108, 927 patients in the Acute Decompensated Heart Failure National Registry. American Heart Journal. 2007; 153: 74-81.
25. Carnethon MR, de Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, et al. Association of weight status with mortality in adults with incident diabetes. JAMA: The Journal of the American Medical Association. 2012; 308: 581-90.
26. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA: The Journal of the American Medical Association. 2005; 293: 1861-7.